Ameridose, LLC: Recall of Unexpired Products in Circulation

by FDA on October 31, 2012

in MedWatch

FDA’s preliminary findings have raised concerns about a lack of sterility assurance for products produced at and distributed by this facility.

This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.

View Full Details Of The Original MedWatch Notice Here.

Leave a Comment

Previous post:

Next post: